Healthcare Value Capital

Healthcare Value Capital as of June 30, 2019

Portfolio Holdings for Healthcare Value Capital

Healthcare Value Capital holds 17 positions in its portfolio as reported in the June 2019 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Gilead Sciences Call Option (GILD) 27.9 $15M 220k 67.56
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY) 11.0 $5.9M 20k 293.00
Glaxosmithkline Sponsored Adr 9.0 $4.8M 120k 40.02
Abbvie Call Option (ABBV) 6.8 $3.6M 50k 72.72
Johnson & Johnson Call Option (JNJ) 6.5 $3.5M 25k 139.28
Ligand Pharmaceuticals Com New Put Option (LGND) 5.4 $2.9M 25k 114.16
Tyme Technologies 5.2 $2.8M 2.3M 1.22
CVS Caremark Corporation Call Option (CVS) 5.1 $2.7M 50k 54.50
Greenlane Hldgs Cl A 4.5 $2.4M 250k 9.59
Pfizer (PFE) 4.1 $2.2M 50k 43.32
Viking Therapeutics (VKTX) 3.9 $2.1M 250k 8.30
Novelion Therapeutics Com New 2.6 $1.4M 1.8M 0.78
Adamas Pharmaceuticals 2.3 $1.2M 200k 6.20
Gw Pharmaceuticals Ads Put Option 1.9 $1.0M 6.0k 172.33
Cronos Group Put Option (CRON) 1.5 $799k 50k 15.98
Antares Pharma Call Option 1.2 $658k 200k 3.29
Proshares Tr Ii Vix Sh Trm Futrs Call Option 1.0 $535k 25k 21.40